The President of an American biosciences company has applauded the University of Leicester for its work into ground-breaking identification of new treatment for infectious hospital bugs.
Phil Young, from AmpliPhi Biosciences Corporation, also commented on his excitement at working with Dr Martha Clokie, the lead scientist at the university.
We are very excited about this partnership with Dr Clokie and the University of Leicester. Phage-based therapy has the potential to revolutionise the way C diff infections are treated in the clinic, in compliance with the regulatory frameworks already in place. We firmly believe that this collaboration may result in a treatment that could benefit patients, clinicians and health-care organisations alike.
More top news
Ukip is hoping for a shock win in the Sleaford and North Hykeham by-election, following the resignation of Tory MP Stephen Phillips.
Britain was warned by the government's immigration adviser it was becoming more divided as diversity increases.
A Christmas fanatic has turned his home into a lights extravaganza by putting up 25,000 of them!